Lawrence Monoson

Director Ejecutivo en

RxData, Inc.

Consumer Services

Finance

Technology Services

Perfil

Lawrence Monoson is the founder and Chief Executive Officer of RxData, Inc. which is founded in 2014.
He is currently an Advisor at Valence Ventures LLC since 2017.
Mr. Monoson completed his undergraduate degree at McGill University in 2009 and his graduate degree at École des Hautes Études Commerciales de Paris in 2012.

Cargos activos de Lawrence Monoson

Empresas	Cargo	Inicio
RxData, Inc. RxData, Inc. Packaged SoftwareTechnology Services Develops platform that provides access to pharmaceutical pricing and clinical data	Director Ejecutivo	01/07/2014
Valence Ventures LLC Valence Ventures LLC Investment ManagersFinance Valence Ventures invests in companies located in the United States. The firm targets companies operating in the fields of software sectors. It provides financing for seed and early stage capital requirements.	Consultor / Asesor	01/01/2017

Todos los cargos activos de Lawrence Monoson

Formación de Lawrence Monoson.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Lawrence Monoson.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	4
McGill University McGill University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
École des Hautes Études Commerciales de Paris École des Hautes Études Commerciales de Paris Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Valence Ventures LLC Valence Ventures LLC Investment ManagersFinance Valence Ventures invests in companies located in the United States. The firm targets companies operating in the fields of software sectors. It provides financing for seed and early stage capital requirements.	Finance
RxData, Inc. RxData, Inc. Packaged SoftwareTechnology Services Develops platform that provides access to pharmaceutical pricing and clinical data	Technology Services